TechNavio's analysts forecast the Global Stem Anticancer Therapeutics market to grow at a CAGR of 11.48 percent over the period 2012-2016. Increasing investment in R&D is one of the key factors contributing to this market growth. The Global Stem Anticancer Therapeutics market has also been witnessing an increasing number of strategic alliances among vendors. However, stringent regulatory approval processes could pose a challenge to the growth of this market.
TechNavio's report, the Global Stem Anticancer Therapeutics Market 2012-2016, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market in the Americas, and the EMEA and APAC regions; it also covers the Global Stem Anticancer Therapeutics market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
The key vendors dominating this space include Celgene Corp., Curis Inc., Exelixis Inc., Gamida Cell Ltd., Lonza Group, Merck & Co. Inc., OncoMed Pharmaceuticals Inc., Pfizer Inc., Roche Holding AG, Teva Pharmaceutical Industries Ltd., and Verastem Inc.
Key questions answered in this report:
What will the market size be in 2016 and what will be the growth rate?
What are key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by key vendors?
What are the strengths and weaknesses of each of these key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details provided within the report.
01. Executive Summary
02. List of Abbreviations
03. Introduction
04. Market Research Methodology
Market Research Process
Research Design
Research Methodology
05. Scope of the Report
Market Overview
06. Stem Cells
06.1 Autologous Cell Therapy
06.2 Allogenic Cell Therapy
07. Market Landscape
07.1 Global Stem Cell Anticancer Therapeutics Market
Market Size and Forecast
07.2 Stem Cell Anticancer Therapeutics Market in the North America
Market Size and Forecast
07.3 Stem Cell Anticancer Therapeutics Market in the Latin and South America
Market Size and Forecast
07.4 Stem Cell Anticancer Therapeutics Market in Europe
Market Size and Forecast
07.5 Stem Cell Anticancer Therapeutics Market in Asia
Market Size and Forecast
07.6 Five Forces Analysis
08. Geographical Segmentation
09. Vendor Landscape
10. Buying Criteria
11. Market Growth Drivers
12. Drivers and their Impact
13. Market Challenges
14. Impact of Drivers and Challenges
15. Market Trends
16. Key Vendor Analysis
16.1 Roche Holding AG
Business Overview
Key Information
SWOT Analysis
16.2 OncoMed Pharmaceuticals Inc.
Business Overview
Key Information
SWOT Analysis
16.3 Celgene Corp.
Business Overview
Key Information
SWOT Analysis
16.4 Merck and Co. Inc.
Business Overview
Key Information
SWOT Analysis
17. Other Reports in this Series
List of Exhibits
Exhibit 1: Market Research Methodology
Exhibit 2: Global Stem Cell Anticancer Therapeutics Market Segmentation
Exhibit 3: Global Stem Cell Anticancer Therapeutics Market 2012-2016 (US$ million)
Exhibit 4: Stem Cell Anticancer Therapeutics Market in the North America 2012-2016 (US$ million)
Exhibit 5: Stem Cell Anticancer Therapeutics Market in the Latin and South America 2012-2016 (US$ million)
Exhibit 6: Stem Cell Anticancer Therapeutics Market in Europe 2012-2016 (US$ million)
Exhibit 7: Stem Cell Anticancer Therapeutics Market in Asia 2012-2016 (US$ million)
Exhibit 8: Global Stem Cell Anticancer Therapeutics Market by Geographical Segmentation 2012
Exhibit 9: Business Segmentation of Roche Holding Ltd.
Exhibit 10: Business Segmentation of Merck & Co. Inc.
Contact us at the Consulting WP office nearest to you or submit a business inquiry online.
Subscribe to Our Newsletter
Published On : November 2019
$ 3600
Published On : November 2019
$ 3600
Published On : November 2019
$ 3600
$ 3950
Published On : April 2019
$ 3000
